Suppr超能文献

相似文献

1
Hyperactivation of JAK1 tyrosine kinase induces stepwise, progressive pruritic dermatitis.
J Clin Invest. 2016 Jun 1;126(6):2064-76. doi: 10.1172/JCI82887. Epub 2016 Apr 25.
2
JAK1/2 inhibition impairs the development and function of inflammatory dendritic epidermal cells in atopic dermatitis.
J Allergy Clin Immunol. 2021 Jun;147(6):2202-2212.e8. doi: 10.1016/j.jaci.2020.11.041. Epub 2020 Dec 15.
3
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib.
Am J Clin Dermatol. 2020 Dec;21(6):783-798. doi: 10.1007/s40257-020-00548-6.
4
Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
J Allergy Clin Immunol. 2014 Jul;134(1):92-9. doi: 10.1016/j.jaci.2014.02.017. Epub 2014 Apr 1.
5
The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.
J Allergy Clin Immunol. 2015 Sep;136(3):667-677.e7. doi: 10.1016/j.jaci.2015.03.051. Epub 2015 Jun 24.
6
Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis.
Yonsei Med J. 2010 Nov;51(6):808-22. doi: 10.3349/ymj.2010.51.6.808.
7
Dysregulated ceramide metabolism in mouse progressive dermatitis resulting from constitutive activation of Jak1.
J Lipid Res. 2023 Feb;64(2):100329. doi: 10.1016/j.jlr.2023.100329. Epub 2023 Jan 11.
8
Atopic dermatitis induces the expansion of thymus-derived regulatory T cells exhibiting a Th2-like phenotype in mice.
J Cell Mol Med. 2016 May;20(5):930-8. doi: 10.1111/jcmm.12806. Epub 2016 Mar 2.
9
An improved mouse model of atopic dermatitis and suppression of skin lesions by an inhibitor of Tec family kinases.
Allergol Int. 2007 Dec;56(4):403-9. doi: 10.2332/allergolint.O-07-486. Epub 2007 Sep 1.

引用本文的文献

1
A refined comparative mouse model of acute and chronic atopic dermatitis.
J Anim Sci Technol. 2025 May;67(3):636-650. doi: 10.5187/jast.2024.e93. Epub 2025 May 31.
2
Molecular mechanisms of obesity predisposes to atopic dermatitis.
Front Immunol. 2024 Nov 4;15:1473105. doi: 10.3389/fimmu.2024.1473105. eCollection 2024.
3
Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis: A systematic review.
PLoS One. 2024 Jul 26;19(7):e0306463. doi: 10.1371/journal.pone.0306463. eCollection 2024.
5
Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer.
Mol Cell Biochem. 2025 Jan;480(1):1-17. doi: 10.1007/s11010-024-04983-5. Epub 2024 Mar 22.
6
Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches.
Clin Rev Allergy Immunol. 2023 Dec;65(3):331-353. doi: 10.1007/s12016-023-08973-1. Epub 2023 Oct 28.
9
JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review.
Front Immunol. 2022 Dec 8;13:1068260. doi: 10.3389/fimmu.2022.1068260. eCollection 2022.
10
Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammation.
JCI Insight. 2022 Dec 22;7(24):e150849. doi: 10.1172/jci.insight.150849.

本文引用的文献

1
Application of moisturizer to neonates prevents development of atopic dermatitis.
J Allergy Clin Immunol. 2014 Oct;134(4):824-830.e6. doi: 10.1016/j.jaci.2014.07.060.
2
Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention.
J Allergy Clin Immunol. 2014 Oct;134(4):818-23. doi: 10.1016/j.jaci.2014.08.005.
3
JAK inhibitors: treatment efficacy and safety profile in patients with psoriasis.
J Immunol Res. 2014;2014:283617. doi: 10.1155/2014/283617. Epub 2014 May 5.
4
Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases.
J Med Chem. 2014 Jun 26;57(12):5023-38. doi: 10.1021/jm401490p. Epub 2014 Jan 23.
5
Targeting interleukin-22 in psoriasis.
Inflammation. 2014 Feb;37(1):94-9. doi: 10.1007/s10753-013-9715-y.
6
An ENU mutagenesis-derived mouse model with a dominant Jak1 mutation resembling phenotypes of systemic autoimmune disease.
Am J Pathol. 2013 Aug;183(2):352-68. doi: 10.1016/j.ajpath.2013.04.027. Epub 2013 Jun 19.
7
IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions.
J Invest Dermatol. 2013 Feb;133(2):479-88. doi: 10.1038/jid.2012.313. Epub 2012 Sep 6.
8
Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation.
J Exp Med. 2012 Jun 4;209(6):1105-19. doi: 10.1084/jem.20112258. Epub 2012 May 7.
9
JAK and STAT signaling molecules in immunoregulation and immune-mediated disease.
Immunity. 2012 Apr 20;36(4):542-50. doi: 10.1016/j.immuni.2012.03.014.
10
Inborn errors of human JAKs and STATs.
Immunity. 2012 Apr 20;36(4):515-28. doi: 10.1016/j.immuni.2012.03.016.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验